Sana Biotechnology Inc (SANA)
2.61
+0.26
(+11.06%)
USD |
NASDAQ |
Nov 22, 16:00
2.68
+0.07
(+2.68%)
After-Hours: 20:00
Sana Biotechnology Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Foghorn Therapeutics Inc | 0.00 |
| Omega Therapeutics Inc | 1.350 |
| Moderna Inc | 0.00 |
| Summit Therapeutics Inc | -- |
| Apellis Pharmaceuticals Inc | 1.907 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 559.39M |
| Total Liabilities (Quarterly) | 266.91M |
| Shareholders Equity (Quarterly) | 292.48M |